(BNTX) – FDA
-
Autolus Therapeutics (AUTL) Enters License and Option Agreement with BioNTech SE (BNTX)
-
BioNTech (BNTX) and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial Cancer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BNTX Stock Lookup